Phytotherapeutic Extract Modules for Telomere Lengthening

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Aging-related diseases pose a significant socio-economic burden due to increased life expectancy and the accumulation of deleterious changes in cells and tissues, with current therapeutic approaches being inadequate in addressing the underlying molecular pathways leading to chronic illnesses.

Innovation Solution

Phytotherapeutic extracts, including Pinetonal, Thyvolve, Bluecosig, Telogenic, Sentophagy, Inflasolve, Stemegenis, CMEnhance, Epiverse, and Elastage ECM, are administered daily to support telomere lengthening and biological homeostasis, addressing multiple aging factors such as mitochondrial dysfunction, cellular senescence, and inflammation through reflux extraction and combination therapy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current therapeutic approaches are used to address aging-related diseases, then treatment of individual diseases is possible, but the underlying molecular pathways leading to chronic illnesses are not effectively addressed and the socio-economic burden continues to rise

Engineering Contradiction:
Improveeffectiveness of therapeutic approachVSAvoidability to address multiple aging pathways
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent segments the complex aging process into distinct molecular pathways (mitochondrial dysfunction, telomere attrition, epigenetic alterations, genomic instability, loss of proteostasis, cellular senescence, imbalanced metabolism, stem cell exhaustion, decreased autophagy function, and immune aging). Each pathway is targeted by specific phytotherapeutic compounds, allowing comprehensive coverage of aging mechanisms through modular treatment approaches.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs composite phytotherapeutic formulations that combine multiple plant-derived compounds with different mechanisms of action. These composite formulations simultaneously target multiple aging pathways, providing a versatile therapeutic approach that addresses the complexity of aging-related diseases more effectively than single-compound treatments.

Inventive Principle:
Principle #40Composite materials

2Reliability

If phytotherapeutic extracts are administered to support telomere lengthening and biological homeostasis, then telomere length increases and C-reactive protein levels decrease, but the complexity of the treatment protocol increases

Engineering Contradiction:
Improvetelomere lengthening effectVSAvoidtreatment protocol complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges multiple phytotherapeutic extracts into integrated treatment protocols that simultaneously address multiple aging pathways. By combining compounds that target telomere maintenance, inflammation, mitochondrial function, and other aging mechanisms, the treatment achieves comprehensive anti-aging effects through a coordinated protocol rather than separate interventions.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent develops universal phytotherapeutic formulations that perform multiple functions: supporting telomere lengthening, reducing inflammatory markers like C-reactive protein, enhancing mitochondrial function, and promoting overall biological homeostasis. This multi-functionality reduces the need for separate targeted treatments for each aging pathway.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Duration of action of stationary object

If daily ingestion of phytotherapeutic extracts is maintained for six months or longer, then significant telomere lengthening and reduced inflammation occur, but the duration and commitment of the treatment regimen increases

Engineering Contradiction:
Improveduration of treatment effectVSAvoidtime commitment for treatment
Core Design Contradiction:
Duration of action of stationary objectVSLoss of time

Solution Approach 1:

The patent employs preliminary action by administering phytotherapeutic extracts that proactively maintain and lengthen telomeres before they become critically short, and by reducing inflammatory markers before they cause significant tissue damage. This preventive approach addresses aging pathways early in the process, requiring sustained but not excessively long treatment duration to achieve meaningful protective effects.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent emphasizes continuous daily ingestion of phytotherapeutic extracts to maintain sustained therapeutic levels of active compounds in the body. This continuity ensures consistent support for telomere maintenance, ongoing reduction of inflammation, and persistent activation of anti-aging pathways, achieving cumulative benefits over the treatment period.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The daily ingestion of these extracts results in significant telomere lengthening and reduced C-reactive protein levels, correlating with decreased biological age, thereby lessening the risk of age-related diseases and promoting overall health and longevity.

Implementation Method 1

In some instances the module component compositions are produced via reflux extraction.

Methodology Applied
Scientific EffectReflux extraction:

Data Source

PatentUS20230320397A1Extracts for health supplements
Publication Date: 2023.10.12 EXTENDED LONGEVITY
  • US20230320397A1 patent drawing
  • US20230320397A1 patent drawing
  • US20230320397A1 patent drawing

AI summary

A cocktail of compositions divided into modules to supplement health or have therapeutic effective by delivering aliquots or doses of one or more consumptions of Pinetonal, Thyvolve, Bluecosig, Telogenic, Sentophagy, Inflasolve, Stemegenis, CMEnhance, Epivers, Elastage ECM, Cnidium, Emophix and Cognilace disclosed herein which have been associated with measured telomere lengthening which is a measure of cellular age.